TNFRSF17 and Miyoshi myopathy: Two CAR-Ts are advanced in their development, idecabtagene vicleucel (ide-cel) and ciltacabtagene autoleucel (cilta-cel), both targeting B cell maturation antigen (BCMA) expressed by MM cells.